Cargando…
IL-25 blockade inhibits metastasis in breast cancer
Metastasis is the leading cause of death in breast cancer patients. However, the mechanisms underlying metastasis are not well understood and there is no effective treatment in the clinic. Here, we demonstrate that in MMTV-PyMT, a highly malignant spontaneous breast tumor model, IL-25 (also called I...
Autores principales: | Jiang, Zhujun, Chen, Jingtao, Du, Xuemei, Cheng, Hang, Wang, Xiaohu, Dong, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326622/ https://www.ncbi.nlm.nih.gov/pubmed/27909985 http://dx.doi.org/10.1007/s13238-016-0345-7 |
Ejemplares similares
-
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
por: Jin, Kideok, et al.
Publicado: (2018) -
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19(high) B lymphocytes
por: Chen, Yu-Li, et al.
Publicado: (2019) -
IL-25 blockade augments antiviral immunity during respiratory virus infection
por: Williams, Teresa C., et al.
Publicado: (2022) -
STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade
por: Varikuti, Sanjay, et al.
Publicado: (2017) -
Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
por: Jang, Gyu-Beom, et al.
Publicado: (2015)